User profiles for Ilke Tunali
 | Ilke TunaliEli Lilly & Company Verified email at lilly.com Cited by 902 |
[HTML][HTML] Non-invasive decision support for NSCLC treatment using PET/CT radiomics
Two major treatment strategies employed in non-small cell lung cancer, NSCLC, are tyrosine
kinase inhibitors, TKIs, and immune checkpoint inhibitors, ICIs. The choice of strategy is …
kinase inhibitors, TKIs, and immune checkpoint inhibitors, ICIs. The choice of strategy is …
Application of radiomics and artificial intelligence for lung cancer precision medicine
I Tunali, RJ Gillies… - Cold Spring …, 2021 - perspectivesinmedicine.cshlp.org
Medical imaging is the standard-of-care for early detection, diagnosis, treatment planning,
monitoring, and image-guided interventions of lung cancer patients. Most medical images are …
monitoring, and image-guided interventions of lung cancer patients. Most medical images are …
[HTML][HTML] Radial gradient and radial deviation radiomic features from pre-surgical CT scans are associated with survival among lung adenocarcinoma patients
The goal of this study was to extract features from radial deviation and radial gradient maps
which were derived from thoracic CT scans of patients diagnosed with lung adenocarcinoma …
which were derived from thoracic CT scans of patients diagnosed with lung adenocarcinoma …
[HTML][HTML] Non-invasive measurement of PD-L1 status and prediction of immunotherapy response using deep learning of PET/CT images
Background Currently, only a fraction of patients with non-small cell lung cancer (NSCLC)
treated with immune checkpoint inhibitors (ICIs) experience a durable clinical benefit (DCB). …
treated with immune checkpoint inhibitors (ICIs) experience a durable clinical benefit (DCB). …
Radiomics of 18F-FDG PET/CT images predicts clinical benefit of advanced NSCLC patients to checkpoint blockade immunotherapy
Introduction Immunotherapy has improved outcomes for patients with non-small cell lung
cancer (NSCLC), yet durable clinical benefit (DCB) is experienced in only a fraction of patients. …
cancer (NSCLC), yet durable clinical benefit (DCB) is experienced in only a fraction of patients. …
Novel clinical and radiomic predictors of rapid disease progression phenotypes among lung cancer patients treated with immunotherapy: an early report
I Tunali, JE Gray, J Qi, M Abdalah, DK Jeong… - Lung Cancer, 2019 - Elsevier
Objectives Immune-checkpoint blockades have exhibited durable responses and improved
long-term survival in a subset of advanced non-small cell lung cancer (NSCLC) patients. …
long-term survival in a subset of advanced non-small cell lung cancer (NSCLC) patients. …
[HTML][HTML] Peritumoral and intratumoral radiomic features predict survival outcomes among patients diagnosed in lung cancer screening
J Pérez-Morales, I Tunali, O Stringfield, SA Eschrich… - Scientific Reports, 2020 - nature.com
The National Lung Screening Trial (NLST) demonstrated that screening with low-dose
computed tomography (LDCT) is associated with a 20% reduction in lung cancer mortality. One …
computed tomography (LDCT) is associated with a 20% reduction in lung cancer mortality. One …
Stability and reproducibility of computed tomography radiomic features extracted from peritumoral regions of lung cancer lesions
Purpose Recent efforts have demonstrated that radiomic features extracted from the
peritumoral region, the area surrounding the tumor parenchyma, have clinical utility in various …
peritumoral region, the area surrounding the tumor parenchyma, have clinical utility in various …
Hypoxia-related radiomics and immunotherapy response: a multicohort study of non-small cell lung cancer
I Tunali, Y Tan, JE Gray, E Katsoulakis… - JNCI Cancer …, 2021 - academic.oup.com
Background Immunotherapy yields survival benefit for some advanced stage non-small cell
lung cancer (NSCLC) patients. Because highly predictive biomarkers of immunotherapy …
lung cancer (NSCLC) patients. Because highly predictive biomarkers of immunotherapy …
Radiomics of 18F Fluorodeoxyglucose PET/CT Images Predicts Severe Immune-related Adverse Events in Patients with NSCLC
Purpose To investigate the performance of pretreatment fluorine 18 ( 18 F) fluorodeoxyglucose
PET/CT radiomics in predicting severe immune-related adverse events (irSAEs) among …
PET/CT radiomics in predicting severe immune-related adverse events (irSAEs) among …
